Propanc Biopharma (PPCB) Other Accumulated Expenses (2022 - 2024)
Propanc Biopharma (PPCB) posted quarterly Other Accumulated Expenses of $27491.0 for Q4 2024, down 9.25% year-over-year from $30293.0 in Q1 2024, and down 7.62% quarter-over-quarter from $29759.0 in Q3 2024.
Propanc Biopharma (PPCB) Other Accumulated Expenses (2022 - 2024) Analysis & Trends
Propanc Biopharma (PPCB) has reported Other Accumulated Expenses for 3 consecutive years, with $27491.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Other Accumulated Expenses fell 9.25% year-over-year to $27491.0; the TTM figure through Dec 2024 stood at $27491.0 (down 9.25% YoY), while the FY2024 annual figure was $29759.0, changed 0.44% from the prior year.
- Other Accumulated Expenses eased to $27491.0 in Q4 2024 per PPCB's latest filing, from $29759.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $30746.0 in Q2 2022 and bottomed at $27491.0 in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $29445.3 across 3 years, with a median of $29759.0 in 2024.
- On a YoY basis, Other Accumulated Expenses climbed as much as 4.12% in 2024 and fell as far as 9.25% in 2024.
- Propanc Biopharma's Other Accumulated Expenses stood at $30746.0 in 2022, then slipped by 1.47% to $30293.0 in 2023, then declined by 9.25% to $27491.0 in 2024.
- Business Quant data shows PPCB's Other Accumulated Expenses at $27491.0 in Q4 2024, $29759.0 in Q3 2024, and $29759.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 27,491.00 |
| Sep 30, 2024 | 29,759.00 |
| Jun 30, 2024 | 29,759.00 |
| Mar 31, 2024 | 28,972.00 |
| Dec 31, 2023 | 30,293.00 |
| Sep 30, 2023 | 28,581.00 |
| Jun 30, 2023 | 29,630.00 |
| Mar 31, 2023 | 29,777.00 |
| Jun 30, 2022 | 30,746.00 |